
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
What Inhibits Natural Killers’ Performance in Tumour
Ines Papak, Elżbieta Chruściel, Katarzyna Dziubek, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 13, pp. 7030-7030
Open Access | Times Cited: 8
Ines Papak, Elżbieta Chruściel, Katarzyna Dziubek, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 13, pp. 7030-7030
Open Access | Times Cited: 8
Showing 8 citing articles:
Therapeutic application of allogeneic hematopoietic stem cells in childhood acute myeloid leukemia
Yin Luo
Deleted Journal (2025), pp. 1-16
Closed Access
Yin Luo
Deleted Journal (2025), pp. 1-16
Closed Access
Development of FAP-Targeted Chimeric Antigen Receptor NK-92 Cells for Non-Small Cell Lung Cancer
Fang Yang, Yanjing Wang, Hongli Zhao, et al.
Discovery Medicine (2023) Vol. 35, Iss. 176, pp. 405-405
Open Access | Times Cited: 11
Fang Yang, Yanjing Wang, Hongli Zhao, et al.
Discovery Medicine (2023) Vol. 35, Iss. 176, pp. 405-405
Open Access | Times Cited: 11
Recombinant Human Interleukin-2 Corrects NK Cell Phenotype and Functional Activity in Patients with Post-COVID Syndrome
А. А. Савченко, I. V. Kudryavtsev, Dmitry Isakov, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 4, pp. 537-537
Open Access | Times Cited: 9
А. А. Савченко, I. V. Kudryavtsev, Dmitry Isakov, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 4, pp. 537-537
Open Access | Times Cited: 9
M1/M2 macrophages: origin, phenotype, methods of production, interaction with natural killer cells and trophoblast
A. S. Zhguleva, Maria Zementova, S. А. Selkov, et al.
Medical Immunology (Russia) (2024) Vol. 26, Iss. 3, pp. 425-448
Open Access | Times Cited: 1
A. S. Zhguleva, Maria Zementova, S. А. Selkov, et al.
Medical Immunology (Russia) (2024) Vol. 26, Iss. 3, pp. 425-448
Open Access | Times Cited: 1
Evaluating Predictors of Quality in Liver NK Cells Among Deceased Donors
Yuki Imaoka, Masahiro Ohira, Toshihiro Nakayama, et al.
Cell Transplantation (2024) Vol. 33
Open Access | Times Cited: 1
Yuki Imaoka, Masahiro Ohira, Toshihiro Nakayama, et al.
Cell Transplantation (2024) Vol. 33
Open Access | Times Cited: 1
Recombinant Human Interleukin-2 Corrects NK Cell Phenotype and Functional Activity in Patients with Post-COVID Syndrome
А. А. Савченко, I. V. Kudryavtsev, Dmitry Isakov, et al.
Cytokines and inflammation (2024) Vol. 20, Iss. 4, pp. 49-66
Open Access
А. А. Савченко, I. V. Kudryavtsev, Dmitry Isakov, et al.
Cytokines and inflammation (2024) Vol. 20, Iss. 4, pp. 49-66
Open Access
Targeting Cancer: Microenvironment and Immunotherapy Innovations
Irena Padzińska-Pruszyńska, Bartłomiej Taciak, Łukasz Kiraga, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 24, pp. 13569-13569
Open Access
Irena Padzińska-Pruszyńska, Bartłomiej Taciak, Łukasz Kiraga, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 24, pp. 13569-13569
Open Access
Overcoming the challenges in translational development of natural killer cell therapeutics: An opinion paper
Hong Qin, Changqiao You, Yan Feng, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 1
Hong Qin, Changqiao You, Yan Feng, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 1